Varengold Bank AG (VG80)
Deutsche Börse Xetra · Germany · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 2.440 |
|---|---|
| 52-week range | 2.300 – 3.000 |
| Return, 1 month / 3 months | −8.3% / −7.6% |
| Return, 1 year / 3 years | −3.2% / −8.3% |
| Trend | Below its 200-day average |
| RSI (14) | 31 |
| Volatility (1 year) | 31.3% |
| Worst drawdown (1 year) | -15.8% |
| Average daily value traded | 0.00M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Varengold Bank AG is a German private bank based in Hamburg. It provides financing for trade and working capital to small and medium-sized businesses, and it works with financial technology companies that offer lending and deposit products to their own customers. The bank serves corporate clients and institutional partners, combining traditional banking services with support for digital finance platforms. Its activities centre on lending, payment-related services and partnership-based banking solutions for companies in Germany and elsewhere in Europe.
On this site Varengold Bank AG appears as a stock on the Deutsche Börse Xetra (Germany), code VG80, with prices in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Varengold Bank AG (VG80) trades on the Deutsche Börse Xetra in Germany. It last closed at EUR 2.440 on 27 October 2026.
Its price-based Market X-Ray is 48 out of 100 (a weak price profile), ranking 410 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 3.2% and over the last three months it fell 7.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Deutsche Börse Xetra
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 48 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -7.0% | ||
| From 52-week high | -14.4% | ||
| Momentum | 44 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -7.6% | ||
| 6-month return | -6.9% | ||
| 12-month return, skipping the last month | 5.6% | ||
| Stability (higher is calmer) | 76 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 31.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -15.8% | ||
| Liquidity | 6 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M EUR | ||
| Zero-volume days | 1.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −4.7% |
|---|---|
| 1 month | −8.3% |
| 3 months | −7.6% |
| 6 months | −6.9% |
| 1 year | −3.2% |
| 3 years | −8.3% |
| 5 years | −34.8% |
Signals
| 50-day / 200-day average | 2.558 / 2.624 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.062 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Deutsche Börse Xetra; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.